Ajanta Pharma Limited

NSE AJANTPHARM.NS

Ajanta Pharma Limited Gross Profit Margin for the year ending March 31, 2024: 73.50%

Ajanta Pharma Limited Gross Profit Margin is 73.50% for the year ending March 31, 2024, a 2.18% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
  • Ajanta Pharma Limited Gross Profit Margin for the year ending March 31, 2023 was 71.93%, a -1.46% change year over year.
  • Ajanta Pharma Limited Gross Profit Margin for the year ending March 31, 2022 was 73.00%, a -3.99% change year over year.
  • Ajanta Pharma Limited Gross Profit Margin for the year ending March 31, 2021 was 76.03%, a 4.07% change year over year.
  • Ajanta Pharma Limited Gross Profit Margin for the year ending March 31, 2020 was 73.06%, a -7.52% change year over year.
Key data
Date Gross Profit Margin Operating Income Margin EBT Margin Net Income Margin
Market news
Loading...
NSE: AJANTPHARM.NS

Ajanta Pharma Limited

CEO Mr. Yogesh Mannalal Agrawal M.B.A
IPO Date July 1, 2002
Location India
Headquarters Ajanta House
Employees 8,073
Sector Health Care
Industries
Description

Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets finished dosages. The company markets and serves various therapeutic segments, such as anti-biotic, anti-malarial, anti-diabetic, cardiology, gynecology, pediatric, respiratory and general health products, dermatology, ophthalmology, and pain management areas. It also provides multivitamins, antibiotics, eye drops, cough syrups, etc. The company serves in India, Africa, rest of Asia, the United States, and internationally. It supplies its products to government bodies, including armed forces, government hospitals, canteens, stores department, etc. The company was founded in 1973 and is headquartered in Mumbai, India.

Similar companies

IPCALAB.NS

Ipca Laboratories Limited

USD 18.35

0.69%

TORNTPHARM.NS

Torrent Pharmaceuticals Limited

USD 37.58

0.68%

APLLTD.NS

Alembic Pharmaceuticals Limited

USD 11.66

0.86%

ALKEM.NS

Alkem Laboratories Limited

USD 60.83

0.86%

NATCOPHARM.NS

NATCO Pharma Limited

USD 14.52

3.84%

StockViz Staff

January 15, 2025

Any question? Send us an email